Effect of desferrioxamine and chronic iron deficiency of heme metabolism--comparison with the porphyrogens 2-allyl-2-isopropylacetamide and 3,5-diethoxycarbonyl-1,4-dihydrocollidine.
D000624:5-Aminolevulinate Synthetase / Q000378:metabolism; D000081:Acetamides / Q000494:pharmacology*; D000502:Allylisopropylacetamide / Q000494:pharmacology*; D000818:Animals; D003577:Cytochrome P-450 Enzyme System / Q000378:metabolism; D003580:Cytochromes / Q000378:metabolism; D003676:Deferoxamine / Q000494:pharmacology*; D003997:Dicarbethoxydihydrocollidine / Q000494:pharmacology*; D006418:Heme / Q000378:metabolism*; D000090463:Iron Deficiencies; D008099:Liver / Q000378:metabolism; D008297:Male; D008930:Mitochondria, Liver / Q000201:enzymology; D011166:Porphyrins / Q000378:metabolism; D011725:Pyridines / Q000494:pharmacology*; D051381:Rats; D013997:Time Factors
D000081:Acetamides; D003580:Cytochromes; D011166:Porphyrins; D011725:Pyridines; D000502:Allylisopropylacetamide; D006418:Heme; D003997:Dicarbethoxydihydrocollidine; D003577:Cytochrome P-450 Enzyme System; D000624:5-Aminolevulinate Synthetase; D003676:Deferoxamine